Group CEO and Managing Director

CEO Americas

Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX

Telix Pharmaceuticals Limited (TLX) Hits Another Roadblock After SEC Subpoena, Shares Fall Again – Hagens Berman

Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis

Telix Announces Record-Breaking Presence at EANM 2025

Global Development Lead – Px

Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company focused on precision medicine for cancer and rare diseases. The Global Development Lead - Px will oversee the development of diagnostic-related products for cancer, managing cross-functional teams to ensure successful execution of product development plans through Phase 3 clinical trials.

Sign up with Google

Sign in with Google